CORC

浏览/检索结果: 共5条,第1-5条 帮助

已选(0)清除 条数/页:   排序方式:
Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B 期刊论文
Advances in Therapy, 2015, 卷号: 32, 期号: 8, 页码: 727-741
作者:  Hou, Jin-Lin*;  Xu, Daozheng;  Shi, Guangfeng;  Wan, Mobin;  Goodman, Zachary
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/03
Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B 期刊论文
ADVANCES IN THERAPY, 2015, 卷号: 32, 期号: 8
作者:  Hou, Jin-Lin;  Xu, Daozheng;  Shi, Guangfeng;  Wan, Mobin;  Goodman, Zachary
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naive Chinese patients with chronic hepatitis B: a randomized, multicenter study. 期刊论文
Hepatology International, 2008, 卷号: 2, 期号: 4, 页码: 486-493
作者:  Yao, Guangbi*;  Chen, ChengWei;  Lu, WeiLun;  Ren, Hong;  Tan, DeMing
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/03
Efficacy and safety of entecavir compared to lamivudine in nucleoside-naive patients with chronic hepatitis B: a randomized double-blind trial in China. 期刊论文
HEPATOLOGY INTERNATIONAL, 2007, 卷号: 1, 期号: 3, 页码: 365-372
作者:  Guangbi Yao;  Chengwei Chen;  Weilun Lu;  Hong Ren;  Deming Tan
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/03
Entecavir (ETV) results in early viral load reduction in chronic hepatitis B (CHB) patients who have failed lamivudine (LVD) therapy: a randomized, placebo-controlled study in China (study ETV-056) 会议论文
作者:  Yao, Guangbi;  Zhou, X.;  Xu, Daozheng;  Wang, B.;  Ren, Hong
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/27


©版权所有 ©2017 CSpace - Powered by CSpace